Advances in the Development of Antiviral Compounds for Rotavirus Infections

Group A rotaviruses (RVAs) are the major cause of severe acute gastroenteritis (AGE) in children under 5 years of age, annually resulting in nearly 130,000 deaths worldwide. Social conditions in developing countries that contribute to decreased oral rehydration and vaccine efficacy and the lack of...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	María Julieta Tohmé, Laura Ruth Delgui
Format:	article
Langue:	EN
Publié:	American Society for Microbiology 2021
Sujets:	Microbiology QR1-502
Accès en ligne:	https://doaj.org/article/c4f9acf65eb1487e8b511935630f3f91
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

id	oai:doaj.org-article:c4f9acf65eb1487e8b511935630f3f91
record_format	dspace
spelling	oai:doaj.org-article:c4f9acf65eb1487e8b511935630f3f912021-11-03T21:15:05ZAdvances in the Development of Antiviral Compounds for Rotavirus Infections2150-751110.1128/mBio.00111-21https://doaj.org/article/c4f9acf65eb1487e8b511935630f3f912021-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00111-21https://doaj.org/toc/2150-7511 Group A rotaviruses (RVAs) are the major cause of severe acute gastroenteritis (AGE) in children under 5 years of age, annually resulting in nearly 130,000 deaths worldwide. Social conditions in developing countries that contribute to decreased oral rehydration and vaccine efficacy and the lack of approved antiviral drugs position RVA as a global health concern.María Julieta TohméLaura Ruth DelguiAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 12, Iss 3 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Microbiology QR1-502
spellingShingle	Microbiology QR1-502 María Julieta Tohmé Laura Ruth Delgui Advances in the Development of Antiviral Compounds for Rotavirus Infections
description	Group A rotaviruses (RVAs) are the major cause of severe acute gastroenteritis (AGE) in children under 5 years of age, annually resulting in nearly 130,000 deaths worldwide. Social conditions in developing countries that contribute to decreased oral rehydration and vaccine efficacy and the lack of approved antiviral drugs position RVA as a global health concern.
format	article
author	María Julieta Tohmé Laura Ruth Delgui
author_facet	María Julieta Tohmé Laura Ruth Delgui
author_sort	María Julieta Tohmé
title	Advances in the Development of Antiviral Compounds for Rotavirus Infections
title_short	Advances in the Development of Antiviral Compounds for Rotavirus Infections
title_full	Advances in the Development of Antiviral Compounds for Rotavirus Infections
title_fullStr	Advances in the Development of Antiviral Compounds for Rotavirus Infections
title_full_unstemmed	Advances in the Development of Antiviral Compounds for Rotavirus Infections
title_sort	advances in the development of antiviral compounds for rotavirus infections
publisher	American Society for Microbiology
publishDate	2021
url	https://doaj.org/article/c4f9acf65eb1487e8b511935630f3f91
work_keys_str_mv	AT mariajulietatohme advancesinthedevelopmentofantiviralcompoundsforrotavirusinfections AT lauraruthdelgui advancesinthedevelopmentofantiviralcompoundsforrotavirusinfections
_version_	1718445420654362624

Advances in the Development of Antiviral Compounds for Rotavirus Infections

Documents similaires